CTOs on the Move

Access Integrated Healthcare

www.accessih.com

 
Founded by Chief Executive Officer Sam Solakyan, Global Holdings, Inc. has excelled in its journey in becoming leaders in each of the industries it has a presence in. Their main responsibility lies in providing their clients with the most premiere level of service. More than just your typical holdings group, Global is a multifaceted company with financial assets and ownership in the radiology, pharmaceuticals, and medical billing and collections industries. Instead of merely buying and selling companies like other holdings groups, Global searches for the less desirable companies with hidden potential and applies its knowledge and expertise in the management ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.accessih.com
  • 550 N. Brand Blvd. 20th Floor
    Glendale, CA USA 91203
  • Phone: 866.460.7465

Executives

Name Title Contact Details

Similar Companies

Cerexa

Cerexa is a Oakland, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BLVDWest

BLVDWest is a Newport Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Omada Health

We`ve pioneered digital behavioral medicine: a new approach to tackling the growing epidemic of type 2 diabetes, heart disease, and obesity. Our online programs combine world-class science, technology, and design to inspire and enable people everywhere to live free of chronic disease. Named one of Fast Company`s “50 Most Innovative Companies in the World,” our team includes passionate and talented individuals from Google, IDEO, Harvard, Stanford, and Columbia. Our approach has been embraced by major employers across the country, including Costco and Iron Mountain, as well as leading health plans, such as Kaiser Permanente and Humana.

J. A. Thomas and Associates

J. A. Thomas and Associates is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ForSight VISION5

ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.